• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Insufficient Information (4580)
Event Type  Injury  
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Event Description
Hysterectomy with extensive blood loss [device ineffective].Case narrative: this initial spontaneous report originating from the united states, was received from a physician referring to a non-pregnant female patient of unknown age.The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant medications were not reported.This report concerned 1 patient and 1 device.On an unknown date, the patient was inserted with vacuum induced hemorrhage control system (jada system) (1 device) via vaginal route (lot #, serial #, and expiry date were not reported) for postpartum hemorrhage by a health care professional (unspecified) at an unknown facility.However, the patient was transferred to the reporting facility for hysterectomy with extensive blood loss (device ineffective, onset date: unknown).The estimated blood loss (ebl/qbl) prior to vacuum-induced hemorrhage control system (jada system) use was 3000 cubic centimeter (cc).The physician was unsure if there was a malfunction of vacuum-induced hemorrhage control system (jada system).The patient sought medical attention.The availability of vacuum-induced hemorrhage control system (jada system) was unknown.Upon internal review, the event of device ineffective was determined to be serious as it required intervention.Medical device reporting criteria: serious injury.Fda code: (health effects health impact per annex f): 4648 insufficient information (there is not yet enough information available to classify the health impact).Fda code: (health effects health impact per annex f): 4624 (one or more surgical procedures was required, or an existing procedure changed).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key16435040
MDR Text Key310138310
Report Number3002806821-2023-00016
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-